Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Stéphane Bach

21PUBLICATIONS

76CO-AUTHORS

Molecular targetsProteins and peptidesBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsNatural products and bioactive compounds

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|Nov 28, 2025

Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Claire Delehouzé, Melodie Mallais, Arnaud Comte

|Oct 29, 2025

Research towards selective inhibition of the CLK3 kinase.

Vinay Kumar Singh, Frédéric Justaud, Dabbugoddu Brahmaiah

|Jun 27, 2025

New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.

José Rivaldo De Lima, Alexandre José Da Silva Góes, Elizabeth Fernanda De Oliveira Borba

|Jun 23, 2025

Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-<i>a</i>]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Lhana Tisseur, Cédric Logé, Sandrine Cojean

|Dec 17, 2024

Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama

|Nov 27, 2024

Novel Thiazole-Fused [4,5-<i>g</i>] or [5,4-<i>g</i>]Quinazolin-8-ones and Their Quinazoline Analogues: Synthesis and Biological Evaluation.

Nathan Broudic, Alexandra Pacheco-Benichou, Cécile Corbière

Pageof 4

Frequent Collaborators

9 joint publications

Blandine Baratte

4 joint publications

Cédric Logé

4 joint publications

Pascal Marchand

3 joint publications

Marc-Antoine Bazin

2 joint publications

Isabelle Ourliac-Garnier

2 joint publications

Fabrice Gouilleux

2 joint publications

Barbara Montanini

2 joint publications

Sandrine Ruchaud

2 joint publications

Silvia Rivara

2 joint publications

Elisabetta Levati

Frequent Collaborators

9 joint publications

Blandine Baratte

4 joint publications

Cédric Logé

4 joint publications

Pascal Marchand

3 joint publications

Marc-Antoine Bazin

Top Related Videos

Revealing the Ferroptotic Phenotype of Medulloblastoma

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on : Mar 15, 2024

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos

Top Related Videos

Revealing the Ferroptotic Phenotype of Medulloblastoma

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on : Mar 15, 2024

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos